Abstract:Alzheimer disease (AD) represents an oncoming epidemic that without an effective treatment promises to exact extraordinary human and financial burdens. Studies of pathogenesis are essential for defining targets for discovering disease-modifying treatments. Past studies of AD neuropathology provided valuable, albeit limited, insights. Nevertheless, building on these findings, recent studies have provided an increasingly rich harvest of genetic, molecular and cellular data that are creating unprecedented opportunities to both understand and treat AD. Among the most significant are those documenting the presence within the AD brain of toxic oligomeric species of Aβ and tau. Existing data support the view that such species can propagate and spread within neural circuits. To place these findings in context we first review the genetics and neuropathology of AD, including AD in Down syndrome (AD-DS). We detail studies that support the existence of toxic oligomeric species while noting the significant unanswered questions concerning their precise structures, the means by which they spread and undergo amplification and how they induce neuronal dysfunction and degeneration. We conclude by offering a speculative synthesis for how oligomers of Aβ and tau initiate and drive pathogenesis. While 100 years after Alzheimer's first report there is much still to learn about pathogenesis and the discovery of disease-modifying treatments, the application of new concepts and sophisticated new tools are poised to deliver important advances for combatting AD.

Intracelluar Aβ accumulation in neurons and the pathogenesis of Alzheimer's disease

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Intracellular A beta and its Pathological Role in Alzheimer's Disease: Lessons from the Cellular to Animal Model

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease

The Role of Intracellular Amyloid Beta in Alzheimer'S Disease

Recent Progress in the Study of Intracellular Toxicity of Amyloid Β Peptide in Alzheimer＇s Disease

Recent Progress in the Study of Intracellular Toxicity of Amyloid Beta Peptide in Alzheimer'S Disease

Functions and Mechanisms of Intracellular Domain of Amyloid Precursor Protein

Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism.

The Release and Transmission of Amyloid Precursor Protein Via Exosomes

[Calcium Dyshomeostasis and Alzheimer's Disease]

Oxidative stress and the pathogenesis of Alzheimer's disease.

Advances in the β-amyloid precursor protein of Alzheimer's disease

Human beta-secretase and Alzheimer's disease

Pathogen Infection in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies

New Insights Into the Pathogenesis of Alzheimer's Disease

Mechanisms of Alzheimer’s Disease Pathogenesis and Prevention: The Brain, Neural Pathology, N-methyl-D-aspartate Receptors, Tau Protein and Other Risk Factors

Amyloid β oligomer induces cerebral vasculopathy via pericyte-mediated endothelial dysfunction

Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species

Advances in Mitochondria Injury by Aβin Alzheimer's Disease

Amyloid-β and Tau in Alzheimer's Disease